Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

globenewswire.com
ABBV AbbVie is mentioned as a key company in the Systemic Lupus Erythematosus market, indicating its involvement in autoimmune disease therapeutics. ABCL Abcam is listed as a key company in the Autoimmune Disease Diagnostics Market, suggesting its role in the broader autoimmune disease landscape. AZN AstraZeneca is identified as a key company in both the Rheumatoid Arthritis Market and the Multiple Sclerosis Market, highlighting its presence in autoimmune disease treatment. BIIB Biogen is mentioned as a key company in both the Systemic Lupus Erythematosus Market and the Multiple Sclerosis Market, indicating its focus on autoimmune disease therapeutics. BMY Bristol Myers Squibb is listed as a key company in both the Systemic Lupus Erythematosus Market and the Multiple Sclerosis Market, showing its involvement in autoimmune disease treatments. EXEL Exelixis is mentioned as a key company in the Autoimmune Disease Diagnostics Market. GILD Gilead Sciences is mentioned as a key company in the Autoimmune Disease Diagnostics Market. GSK GlaxoSmithKline is listed as a key company in the Multiple Sclerosis Market, indicating its role in autoimmune disease therapeutics. INCY Incyte is mentioned as a key company in the Rheumatoid Arthritis Market, indicating its involvement in autoimmune disease therapeutics. LRCX Lam Research is mentioned as a key company in the Autoimmune Disease Diagnostics Market. MRK Merck is mentioned as a key company in the Autoimmune Disease Diagnostics Market. NVS Novartis is listed as a key company in both the Systemic Lupus Erythematosus Market and the Multiple Sclerosis Market, showing its involvement in autoimmune disease treatments. PFE Pfizer is mentioned as a key company in the Psoriatic Arthritis Market, indicating its role in autoimmune disease therapeutics. REGN Regeneron Pharmaceuticals is mentioned as a key company in the Autoimmune Disease Diagnostics Market. SNY Sanofi is listed as a key company in the Multiple Sclerosis Market, indicating its role in autoimmune disease therapeutics. TMO Thermo Fisher Scientific is listed as a key company in the Autoimmune Disease Diagnostics Market, indicating its involvement in the autoimmune disease landscape. UCB UCB is mentioned as a key company in the Rheumatoid Arthritis Market, Psoriatic Arthritis Market, and Systemic Lupus Erythematosus Market, highlighting its focus on autoimmune disease therapeutics. VRTX Vertex Pharmaceuticals is mentioned as a key company in the Autoimmune Disease Diagnostics Market.

Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight New York, USA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

The autoimmune disease therapeutics market is experiencing steady growth, driven by the rising prevalence and improved diagnosis of autoimmune disorders such as rheumatoid arthritis, psoriasis, multiple sclerosis, systemic lupus erythematosus, and inflammatory bowel disease. Increasing adoption of biologics and targeted therapies, including TNF, interleukin, B-cell, and JAK inhibitors, is expanding treatment options and supporting long-term market demand. The market is also benefiting from growing investment in novel immunology pipelines, with cell-based approaches such as CAR-T and B-cell-directed therapies emerging as potential options for patients with severe or treatment-refractory disease.

DelveInsight’s Autoimmune Disease Therapeutics Market Insights report provides the current and forecast market analysis, individual leading autoimmune disease therapeutics companies’ market shares, challenges, autoimmune disease therapeutics market drivers, barriers, trends, and key autoimmune disease therapeutics companies in the market.

Autoimmune Disease Therapeutics Market Summary

To read more about the strategies to implement autoimmune disease therapeutics, get a snapshot @ https://www.delveinsight.com/report-store/autoimmune-disease-therapeutics-market

Key Factors Contributing to the Rise in Growth of the Autoimmune Disease Therapeutics Market

Get a sneak peek at the autoimmune disease therapeutics market dynamics @ Autoimmune Disease Therapeutics Market Trends

Regional Autoimmune Disease Therapeutics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the autoimmune disease therapeutics market, get a snapshot of the Autoimmune Disease Therapeutics Market Share

Recent Developmental Activities in the Autoimmune Disease Therapeutics Market

What is Autoimmune Disease Therapeutics?

Autoimmune disease therapeutics refer to medicines and treatment approaches designed to manage autoimmune disorders, in which the immune system mistakenly attacks the body’s own healthy cells, tissues, or organs. These therapies primarily aim to reduce abnormal immune activity, control inflammation, relieve symptoms, prevent disease progression, and minimize tissue or organ damage. Treatment options include immunosuppressants, corticosteroids, biologic therapies, targeted synthetic drugs, and newer cell- and gene-based approaches that selectively modulate specific immune pathways. Common therapeutic targets include cytokines, immune cells, and signaling pathways involved in autoimmune responses. Major autoimmune diseases treated with these therapies include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, inflammatory bowel disease, and type 1 diabetes. Growing understanding of disease mechanisms and advances in precision medicine are supporting the development of more targeted and effective therapies with improved safety profiles.

Autoimmune Disease Therapeutics Market Assessment

Which MedTech key players in the autoimmune disease therapeutics market are set to emerge as the trendsetter explore @ Autoimmune Disease Therapeutics Market Analysis

Table of Contents

Interested in knowing the autoimmune disease therapeutics market share by 2034? Click to get a snapshot of the Top Autoimmune Disease Therapeutics

Related Reports

Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key autoimmune disease diagnostics companies, including Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech and Biomerieux SA., and others.

Rheumatoid Arthritis Market

Rheumatoid Arthritis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key rheumatoid arthritis companies, including Cyxone, Taiho Pharmaceutical, AstraZeneca, Eli Lilly and Company, Rise Therapeutics, TNF Pharmaceuticals, Incyte, UCB, and others.

Psoriatic Arthritis Market

Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key PsA companies, including UCB Biopharma, Sun Pharmaceutical Industries Limited, BMS, Affibody AB, Janssen Biotech, Amgen, Eli Lilly and Company, AbbVie, Pfizer, and others.

Systemic Lupus Erythematosus Market

Systemic Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key SLE companies including Biogen, Novartis, MorphoSys, Idorsia Pharmaceuticals, Viatris, RemeGen, UCB Pharma, Genentech, Bristol Myers Squibb, AbbVie, and others.

Multiple Sclerosis Market

Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key multiple sclerosis companies including Immune Response BioPharma, Inc., Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., Bristol-Myers Squibb, TG Therapeutics, Inc., Hoffmann-La Roche, Atara Biotherapeutics, Immunic AG, Celgene, Anokion SA, Sanofi, Actelion, Biogen, Supernus Pharmaceuticals, Inc., GeNeuro SA, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, RemeGen Co., Ltd., Antisense Therapeutics, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, Solstice Neurosciences, ProJenX, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.